| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,322 | 1,349 | 14.11. | |
| 1,298 | 1,374 | 14.11. |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | Protalix Biotherapeutics Aktie: Erfolgsstrategie geht auf! | Das israelische Biotechnologieunternehmen Protalix BioTherapeutics verzeichnete im dritten Quartal 2024 einen unerwarteten Gewinn. Der Nettogewinn belief sich auf 3,24 Millionen Dollar oder 0,03 Dollar... ► Artikel lesen | |
| Do | Protalix BioTherapeutics Reports Profit In Q3; Announces Positive Phase 1 Data For PRX-115 | JERUSALEM (dpa-AFX) - Protalix BioTherapeutics, Inc. (PLX) Thursday reported net income of $3.24 million or $0.03 per share for the third quarter compared with net loss of $1.85 million or $0.04... ► Artikel lesen | |
| Do | Protalix BioTherapeutics Inc. Q3 Earnings Summary | JERUSALEM (dpa-AFX) - Below are the earnings highlights for Protalix BioTherapeutics Inc. (PLX):Earnings: $3.24 million in Q3 vs. -$1.85 million in the same period last year.
EPS: $0.03 in... ► Artikel lesen | |
| Do | Protalix BioTherapeutics GAAP EPS of $0.03, revenue of $17.96M | ||
| Do | Protalix BioTherapeutics, Inc.: Protalix BioTherapeutics Reports Third Quarter 2024 Financial and Business Results | Company to host conference call and webcast today at 8:30 a.m. EST
CARMIEL, Israel, Nov. 14, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE-American:... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | % |
|---|---|---|
| PROTALIX BIOTHERAPEUTICS INC | 1,334 | +13,15 % |
